Evidence map›Paper›PMID 40705081›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Gut microbiota metabolic axis dysfunction in estrogen deficient stressed rats.

Rishabh Chaudhary, Nitin Bansal, Amanpreet Kaur, Sumeet Gupta, Kanwaljit Chopra, Seema Bansal

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rishabh ChaudharyDepartment of Pharmacology, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, Haryana, India.ORCID 0000-0002-7835-7371
Nitin BansalDepartment of Pharmaceutical Sciences, Chaudhary Bansi Lal University, Bhiwani, India.
Amanpreet KaurSchool of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
Sumeet GuptaDepartment of Pharmacology, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, Haryana, India.
Kanwaljit ChopraDepartment of Pharmacology, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India.
Seema BansalDepartment of Pharmacology, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, Haryana, India. 2006.seema@gmail.com.ORCID 0000-0002-2889-0004

Funding

Haryana State Council for Science Innovation & Technology HSCSIT/R&D/2022/2954
6 · The paper itself

Abstract

Gut dysbiosis, an imbalance in the gut microbiota (GM), has emerged as a key factor contributing to metabolic dysfunction following estrogen deficiency in menopause. Disruptions in gut microbial composition, triggered by hormonal imbalances and chronic stress, can exacerbate metabolic disturbances, such as obesity, dyslipidemia, and diabetes etc. Thus strategies, which modulates gut dysbiosis may proves important for the treatment of metabolic dysfunctions in postmenopausal state. However, the physiological, biochemical and molecular changes occurring due to estrogen deficiency and stress are yet to be elucidated. Thus, aim of the present study was to develop a pre-clinical model to investigate the effect of estrogen deficiency and chronic unpredictable mild stress (CUMS) alone and in combination on GM alterations and associated metabolic dysfunction. Ovariectomized (OVX) rats were subjected to CUMS for 28 days to induce metabolic alterations and gut dysbiosis. Estrogen deficiency and chronic stress altered physiological changes, adiposity, and anthropometric markers. Furthermore, OVX and CUMS elevated oxidative stress in liver and colon and increased inflammatory markers as detected in serum, Liver, and colon. This, in turn, led to damage of the mucosal layer and disruption of tight junction proteins. OVX and CUMS also caused gut dysbiosis, as indicated by an increased ratio of pathogenic to beneficial gut bacterial populations. Histopathological examination showed colon and liver tissues damage in OVX, CUMS, and OVX + CUMS group rats. OVX and CUMS, both individually and synergistically, contributed to the development of gut and metabolic dysfunction, collectively referred to as gut-metabolic axis dysfunction in OVX-stressed rats.

Indexed as

DysbiosisEstrogensGastrointestinal MicrobiomeStress, PsychologicalAnimalsColonDisease Models, AnimalFemaleLiverOvariectomyOxidative StressRatsRats, WistarEstrogensCUMSEstrogenGut dysbiosisGut microbiotaMenopauseMetabolic dysfunction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.